Constellation EZH2 inhibitor
long-residence time EZH2 inhibitor oral efficacy in xenograft model from optimatization of prior EZH2 inhibitor ACS Med. Chem. Lett., Mar. 26, 2020 Constellation Pharma., Cambridge, MA
Molecules of the Month - March 2020
Molecules of the Month
- CC-92480
- “PROTAC 6”
- GSK620
- Merck hArg1 inhibitor
- Merck IDO1 inhibitor
- Constellation EZH2 inhibitor
- Arcus CD73 inhibitor
- MK-6884
- sulfopin
- M3814
- remibrutinib